- News
Enables initiation of global EquilibriX-S trial later this year Critical milestone in development of novel bypass agent to restore coagulation,...
- Management TeamNews
News & events
News & events
- News
Enables initiation of global EquilibriX-S trial later this year Critical milestone in development of novel bypass agent to restore coagulation,...
- Management TeamNews
- Conferences & Events
Most competitive selection process so far since the launch of the Accelerator under Horizon Europe Follow-on funding reflects significant potential...
- Conferences & Events
Leiden, The Netherlands, 10 December 2024 – VarmX, a biotech company developing innovative approaches for the bypass of direct oral...
- Conferences & Events
Oral and poster presentations on key VMX-001 data in San Diego from 7-10 December Leiden, The Netherlands, 3 December 2024...
- Conferences & Events
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces that it...
- Conferences & Events
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces that it...
- Management TeamNews
Leadership team fully strengthened to drive next phase of development Leiden, The Netherlands, 12 november 2024 VarmX, a biotech company...
- Management TeamNews
Leiden, The Netherlands, 10 september 2024 VarmX, a biotech company focusing on the development of innovative approaches for the reversal...